Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Shulan Synthetic Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical manufacturer specializing in the production of active pharmaceutical ingredients (APIs) and chemical intermediates. Located in Shulan, Jilin Province, the company is recognized as one of the world's largest producers of xanthine derivatives, including caffeine, theophylline, and aminophylline. Its manufacturing facilities operate under strict GMP standards, supplying high-quality bulk drugs to both domestic and international markets. The company's products are essential components in medications targeting the central nervous system and respiratory conditions. Jilin Shulan Synthetic Pharmaceutical plays a critical role in the global pharmaceutical supply chain for stimulant and bronchodilator compounds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Shulan Synthetic Pharmaceutical.